Literature DB >> 29181157

Non-syndromic isolated dominant optic atrophy caused by the p.R468C mutation in the AFG3 like matrix AAA peptidase subunit 2 gene.

Davide Colavito1, Veronica Maritan2, Agnese Suppiej3, Elda Del Giudice1, Monica Mazzarolo2, Stefania Miotto4, Sofia Farina1, Maurizio Dalle Carbonare1, Stefano Piermarocchi5, Alberta Leon1.   

Abstract

Autosomal dominant optic atrophy (DOA) is the most frequent form of hereditary optic atrophy, a disease presenting with considerable inter- and intra-familial clinical variability. Although a number of mutations in different genes are now known to cause DOA, many cases remain undiagnosed. In an attempt to identify the underlying genetic defect, whole exome sequencing was performed in a 19-year-old male that had been affected by isolated DOA since childhood. The exome sequencing revealed a pathogenic mutation (p.R468C, c.1402C>T) in the AFG3 like matrix AAA peptidase subunit 2 (AFG3L2) gene, a gene known to be associated with spinocerebellar ataxia. The patient did not show any signs other than DOA. Thus, the result demonstrates the possibility that mutations in the AFG3L2 gene may be a cause of isolated autosomal DOA.

Entities:  

Keywords:  AFG3 like matrix AAA peptidase subunit 2; ataxia; exome sequencing; optic atrophy; spinocerebellar ataxia-28

Year:  2017        PMID: 29181157      PMCID: PMC5700392          DOI: 10.3892/br.2017.987

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  23 in total

1.  OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract.

Authors:  P Reynier; P Amati-Bonneau; C Verny; A Olichon; G Simard; A Guichet; C Bonnemains; F Malecaze; M C Malinge; J B Pelletier; P Calvas; H Dollfus; P Belenguer; Y Malthièry; G Lenaers; D Bonneau
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

Review 2.  Dominant optic atrophy.

Authors:  Guy Lenaers; Christian Hamel; Cécile Delettre; Patrizia Amati-Bonneau; Vincent Procaccio; Dominique Bonneau; Pascal Reynier; Dan Milea
Journal:  Orphanet J Rare Dis       Date:  2012-07-09       Impact factor: 4.123

3.  WFS1 in Optic Neuropathies: Mutation Findings in Nonsyndromic Optic Atrophy and Assessment of Clinical Severity.

Authors:  Joanna Grenier; Isabelle Meunier; Vincent Daien; Corinne Baudoin; François Halloy; Béatrice Bocquet; Catherine Blanchet; Cécile Delettre; Etienne Esmenjaud; Agathe Roubertie; Guy Lenaers; Christian P Hamel
Journal:  Ophthalmology       Date:  2016-07-07       Impact factor: 12.079

4.  A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.

Authors:  Mikko Muona; Samuel F Berkovic; Leanne M Dibbens; Karen L Oliver; Snezana Maljevic; Marta A Bayly; Tarja Joensuu; Laura Canafoglia; Silvana Franceschetti; Roberto Michelucci; Salla Markkinen; Sarah E Heron; Michael S Hildebrand; Eva Andermann; Frederick Andermann; Antonio Gambardella; Paolo Tinuper; Laura Licchetta; Ingrid E Scheffer; Chiara Criscuolo; Alessandro Filla; Edoardo Ferlazzo; Jamil Ahmad; Adeel Ahmad; Betul Baykan; Edith Said; Meral Topcu; Patrizia Riguzzi; Mary D King; Cigdem Ozkara; Danielle M Andrade; Bernt A Engelsen; Arielle Crespel; Matthias Lindenau; Ebba Lohmann; Veronica Saletti; João Massano; Michael Privitera; Alberto J Espay; Birgit Kauffmann; Michael Duchowny; Rikke S Møller; Rachel Straussberg; Zaid Afawi; Bruria Ben-Zeev; Kaitlin E Samocha; Mark J Daly; Steven Petrou; Holger Lerche; Aarno Palotie; Anna-Elina Lehesjoki
Journal:  Nat Genet       Date:  2014-11-17       Impact factor: 38.330

5.  Effective diagnosis of genetic disease by computational phenotype analysis of the disease-associated genome.

Authors:  Tomasz Zemojtel; Sebastian Köhler; Luisa Mackenroth; Marten Jäger; Jochen Hecht; Peter Krawitz; Luitgard Graul-Neumann; Sandra Doelken; Nadja Ehmke; Malte Spielmann; Nancy Christine Oien; Michal R Schweiger; Ulrike Krüger; Götz Frommer; Björn Fischer; Uwe Kornak; Ricarda Flöttmann; Amin Ardeshirdavani; Yves Moreau; Suzanna E Lewis; Melissa Haendel; Damian Smedley; Denise Horn; Stefan Mundlos; Peter N Robinson
Journal:  Sci Transl Med       Date:  2014-09-03       Impact factor: 17.956

6.  A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect.

Authors:  D L Thiselton; C Alexander; A Morris; S Brooks; T Rosenberg; H Eiberg; B Kjer; P Kjer; S S Bhattacharya; M Votruba
Journal:  Hum Genet       Date:  2001-10-03       Impact factor: 4.132

7.  From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline.

Authors:  Geraldine A Van der Auwera; Mauricio O Carneiro; Christopher Hartl; Ryan Poplin; Guillermo Del Angel; Ami Levy-Moonshine; Tadeusz Jordan; Khalid Shakir; David Roazen; Joel Thibault; Eric Banks; Kiran V Garimella; David Altshuler; Stacey Gabriel; Mark A DePristo
Journal:  Curr Protoc Bioinformatics       Date:  2013

8.  A novel missense mutation in AFG3L2 associated with late onset and slow progression of spinocerebellar ataxia type 28.

Authors:  Anna Mareike Löbbe; Jun-Suk Kang; Rüdiger Hilker; Holger Hackstein; Ulrich Müller; Dagmar Nolte
Journal:  J Mol Neurosci       Date:  2013-11-29       Impact factor: 3.444

9.  Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases.

Authors:  Tyler Mark Pierson; David Adams; Florian Bonn; Paola Martinelli; Praveen F Cherukuri; Jamie K Teer; Nancy F Hansen; Pedro Cruz; James C Mullikin For The Nisc Comparative Sequencing Program; Robert W Blakesley; Gretchen Golas; Justin Kwan; Anthony Sandler; Karin Fuentes Fajardo; Thomas Markello; Cynthia Tifft; Craig Blackstone; Elena I Rugarli; Thomas Langer; William A Gahl; Camilo Toro
Journal:  PLoS Genet       Date:  2011-10-13       Impact factor: 5.917

Review 10.  The optic nerve: a "mito-window" on mitochondrial neurodegeneration.

Authors:  Alessandra Maresca; Chiara la Morgia; Leonardo Caporali; Maria Lucia Valentino; Valerio Carelli
Journal:  Mol Cell Neurosci       Date:  2012-08-15       Impact factor: 4.314

View more
  8 in total

1.  Unique Structural Features of the Mitochondrial AAA+ Protease AFG3L2 Reveal the Molecular Basis for Activity in Health and Disease.

Authors:  Cristina Puchades; Bojian Ding; Albert Song; R Luke Wiseman; Gabriel C Lander; Steven E Glynn
Journal:  Mol Cell       Date:  2019-07-18       Impact factor: 17.970

2.  A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy.

Authors:  Valentina Baderna; Joshua Schultz; Lisa S Kearns; Michael Fahey; Bryony A Thompson; Jonathan B Ruddle; Aamira Huq; Francesca Maltecca
Journal:  Acta Neuropathol Commun       Date:  2020-06-29       Impact factor: 7.801

Review 3.  Gene Therapy to the Retina and the Cochlea.

Authors:  Ryan Crane; Shannon M Conley; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Front Neurosci       Date:  2021-03-17       Impact factor: 4.677

4.  Dominant mutations in MIEF1 affect mitochondrial dynamics and cause a singular late onset optic neuropathy.

Authors:  Majida Charif; Yvette C Wong; Soojin Kim; Agnès Guichet; Catherine Vignal; Xavier Zanlonghi; Philippe Bensaid; Vincent Procaccio; Dominique Bonneau; Patrizia Amati-Bonneau; Pascal Reynier; Dimitri Krainc; Guy Lenaers
Journal:  Mol Neurodegener       Date:  2021-02-25       Impact factor: 14.195

5.  A novel mutation located in the intermembrane space domain of AFG3L2 causes dominant optic atrophy through decreasing the stability of the encoded protein.

Authors:  Lin Yang; Xiuxiu Jin; Ya Li; Qingge Guo; Mingzhu Yang; Ya You; Shun Yao; Xiaoli Zhang; Zhongfeng Wang; Bo Lei
Journal:  Cell Death Discov       Date:  2022-08-15

6.  Mutations in the m-AAA proteases AFG3L2 and SPG7 are causing isolated dominant optic atrophy.

Authors:  Majida Charif; Arnaud Chevrollier; Naïg Gueguen; Céline Bris; David Goudenège; Valérie Desquiret-Dumas; Stéphanie Leruez; Estelle Colin; Audrey Meunier; Catherine Vignal; Vasily Smirnov; Sabine Defoort-Dhellemmes; Isabelle Drumare Bouvet; Cyril Goizet; Marcela Votruba; Neringa Jurkute; Patrick Yu-Wai-Man; Francesca Tagliavini; Leonardo Caporali; Chiara La Morgia; Valerio Carelli; Vincent Procaccio; Xavier Zanlonghi; Isabelle Meunier; Pascal Reynier; Dominique Bonneau; Patrizia Amati-Bonneau; Guy Lenaers
Journal:  Neurol Genet       Date:  2020-05-20

7.  Upregulation of Peroxiredoxin 3 Protects Afg3l2-KO Cortical Neurons In Vitro from Oxidative Stress: A Paradigm for Neuronal Cell Survival under Neurodegenerative Conditions.

Authors:  Barbara Bettegazzi; Ilaria Pelizzoni; Floramarida Salerno Scarzella; Lisa Michelle Restelli; Daniele Zacchetti; Francesca Maltecca; Giorgio Casari; Fabio Grohovaz; Franca Codazzi
Journal:  Oxid Med Cell Longev       Date:  2019-10-31       Impact factor: 6.543

8.  ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy.

Authors:  Leonardo Caporali; Stefania Magri; Andrea Legati; Valentina Del Dotto; Francesca Tagliavini; Francesca Balistreri; Alessia Nasca; Chiara La Morgia; Michele Carbonelli; Maria L Valentino; Eleonora Lamantea; Silvia Baratta; Ludger Schöls; Rebecca Schüle; Piero Barboni; Maria L Cascavilla; Alessandra Maresca; Mariantonietta Capristo; Anna Ardissone; Davide Pareyson; Gabriella Cammarata; Lisa Melzi; Massimo Zeviani; Lorenzo Peverelli; Costanza Lamperti; Stefania B Marzoli; Mingyan Fang; Matthis Synofzik; Daniele Ghezzi; Valerio Carelli; Franco Taroni
Journal:  Ann Neurol       Date:  2020-04-21       Impact factor: 11.274

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.